Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
33.89
-0.47 (-1.37%)
At close: Aug 21, 2026, 4:00 PM EDT
33.97
+0.08 (0.23%)
After-hours: Aug 21, 2026, 6:02 PM EDT
Viking Therapeutics Stock Forecast
Stock Price Forecast
According to 20 analysts polled by S&P Global, Viking Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $92.39. The average 1-year stock price forecast is 172.62% higher than the current stock price, while the lowest is $35 (+3.28%) and the highest is $125 (+268.84%).
Price Target: $92.39 (+172.62%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Viking Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 12 | 13 | 13 | 13 | 13 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19 | 19 | 20 | 20 | 20 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $100 | Buy | Maintains | $100 | +195.07% | Aug 14, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $75 → $65 | Buy | Maintains | $75 → $65 | +91.80% | Aug 11, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $100 | Buy | Maintains | $100 | +195.07% | Aug 3, 2026 |
| Maxim Group | Maxim Group | Buy Reiterates $70 | Buy | Reiterates | $70 | +106.55% | Jul 31, 2026 |
| Jefferies | Jefferies | Buy Maintains $101 | Buy | Maintains | $101 | +198.02% | Jul 30, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-4.61
from -3.19
EPS Next Year
-4.32
from -4.61
EPS and Forward PE are based on non-GAAP adjusted numbers.